Blastic Plasmacytoid Dendritic Cell Neoplasm in 2020 and Beyond
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive blood cancer with poor patient outcomes. Relatively little was known about the pathobiology and therapeutic sensitivities of the disease until recently. Consequently, the approach to the patient was uninformed, empiric, and inadequate.
Source: Hematology/Oncology Clinics of North America - Category: Cancer & Oncology Authors: Andrew A. Lane Tags: Preface Source Type: research